Cardiac Troponin T Elevation After Stroke: Relationships Between Elevated Serum Troponin T, Stroke Location, and Prognosis
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background and Purpose: Elevation of serum cardiac troponin T (cTnT) is regarded as a specific marker of acute coronary syndrome. Serum cTnT can be increased in patients with acute ischemic stroke, but its clinical implications remain unclear. The aim of this study was to identify the relationships between elevated cTnT and stroke severity, location, and prognosis. Methods: From January 2005 to December 2006, this study recruited 455 consecutive patients who were admitted to Kangbuk Samsung Hospital due to acute ischemic stroke within 3 days of onset, which was confirmed by diffusion magnetic resonance imaging. A total of 416 patients was finally included and divided into 2 groups: an elevated cTnT group (n=45) and a normal cTnT group (n=371). The short-term prognosis was assessed by 30-day modified Rankin Scale responder analysis was compared between the two groups. Results: Serum cTnT was elevated in 10.8% of cases, with elevated cTnT associated with greater stroke severity, as assessed by the National Institutes of Health Stroke Scale score, Insular-lobe involvement was more common in patients with elevated cTnT than in the normal cTnT group. Short-term prognosis was more unfavorable in the elevated cTnT group than in the normal cTnT group. Multivariate regression analysis indicated that elevated cTnT was independently related to insular involvement, cardioembolism, and unfavorable outcome. Conclusions: Elevated cTnT in acute ischemic stroke was associated with severe neurological deficits at stroke onset and damages to the insular lobe. The outcome of acute ischemic stroke was worse for patients with elevated cTnT than for those with normal cTnT. The pathomechanism underlying acute ischemic stroke and subclinical myocardial damage warrants further study.
Abstract
Background and Purpose: Elevation of serum cardiac troponin T (cTnT) is regarded as a specific marker of acute coronary syndrome. Serum cTnT can be increased in patients with acute ischemic stroke, but its clinical implications remain unclear. The aim of this study was to identify the relationships between elevated cTnT and stroke severity, location, and prognosis. Methods: From January 2005 to December 2006, this study recruited 455 consecutive patients who were admitted to Kangbuk Samsung Hospital due to acute ischemic stroke within 3 days of onset, which was confirmed by diffusion magnetic resonance imaging. A total of 416 patients was finally included and divided into 2 groups: an elevated cTnT group (n=45) and a normal cTnT group (n=371). The short-term prognosis was assessed by 30-day modified Rankin Scale responder analysis was compared between the two groups. Results: Serum cTnT was elevated in 10.8% of cases, with elevated cTnT associated with greater stroke severity, as assessed by the National Institutes of Health Stroke Scale score, Insular-lobe involvement was more common in patients with elevated cTnT than in the normal cTnT group. Short-term prognosis was more unfavorable in the elevated cTnT group than in the normal cTnT group. Multivariate regression analysis indicated that elevated cTnT was independently related to insular involvement, cardioembolism, and unfavorable outcome. Conclusions: Elevated cTnT in acute ischemic stroke was associated with severe neurological deficits at stroke onset and damages to the insular lobe. The outcome of acute ischemic stroke was worse for patients with elevated cTnT than for those with normal cTnT. The pathomechanism underlying acute ischemic stroke and subclinical myocardial damage warrants further study.
참고문헌 (29)
- James P, "Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study", BMJ, 320, pp.1502~1504 (2000)
- Yasue H, "Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure", Circulation, 90, pp.195~203 (1994)
- Inoue S, "Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation", J Card Fail, 6, pp.92~96 (2000)
- Takahashi K, "Human brain natriuretic peptide-like immunoreactivity in human brain", Peptides, 13, pp.121~123 (1992)
- Wijdicks EF, "Natriuretic peptide system and endothelin in aneurysmal subarachnoid hemorrhage", J Neurosurg, 87, pp.275~280 (1997)
- Sviri GE, "Brain natriuretic peptide and cerebral vasospasm in subarachnoid hemorrhage: clinical and TCD correlations", Stroke, 31, pp.118~122 (2000)
- Levy A, "The exiting causes of ventricular fibrillation in animals under chloroform anesthesia", Heart, 4, pp.319~378 (1913)
- Norris JW, "Serum cardiac enzymes in stroke", Stroke, 10, pp.548~553 (1979)
- Myers MG, "Cardiac sequelae of acute stroke", Stroke, 13, pp.838~842 (1982)
- Christensen H, ". Serum cardiac troponin I in acute stroke is related to serum cortisol and TNF-alpha", Cerebrovasc Dis, 18, pp.194~199 (2004)
- Trooyen M, "Myocardial injury in acute stroke assessed by troponin I", Tidsskr Nor Laegeforen, 121, pp.421~425 (2001)
- . Di Angelantonio E, "Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke", J Neurol Neurosurg Psychiatry, 76, pp.76~81 (2005)
- Ay H, "Neuroanatomic correlates of stroke- related myocardial injury", Neurology, 66, pp.1325~1329 (2006)
- Barber M, "Elevated troponin levels are associated with sympathoadrenal activation in acute ischemic stroke", Cerebrovasc Dis, 23, pp.260~266 (2007)
- Etgen T, "Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis", Stroke, 36, pp.270~275 (2005)
- Klingelhöfer J, "Cardiovascular consequences of clinical stroke", Baillieres Clin Neurol, 6, pp.309~335 (1997)
- Connor RC, "Heart damage associated with intracranial lesions", Br Med J, 3, pp.29~31 (1968)
- Weidler DJ, "Myocardial damage and cardiac arrhythmias after intracranial hemorrhage. A critical review", Stroke, 5, pp.759~764 (1974)
- Jacob WA, "Myocardial ultrastructure and haemodynamic reactions during experimental subarachnoid haemorrhage", J Mol Cell Cardiol, 4, pp.287~298 (1972)
- Raab W, "Sympathogenic origin and antiadrenergic prevention of stress-induced myocardial lesions", Am J Cardiol, 8, pp.203~211 (1961)
- Oppenheimer SM, "Insular cortex stimulation produces lethal cardiac arrhythmias: a mechanism of sudden death", Brain Res, 550, pp.115~121 (1991)
- Oppenheimer SM, "Cardiac chronotropic organization of the rat insular cortex", Brain Res, 533, pp.66~72 (1990)
- Cechetto DF, "Autonomic and myocardial changes in middle cerebral artery occlusion: stroke models in the rat", Brain Res, 502, pp.296~305 (1989)
- Alpert JS, "Joint European Society of Cardiology", American College of Cardiology Committee. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology, J Am Coll Cardiol, pp.2000, 36(3)[DOI]
- Adams HP Jr, "Measuring outcomes as a function of baseline severity of ischemic stroke", Cerebrovasc Dis, 18, pp.124~129 (2004)
- Advisory Council for the National Institute of Neurological Diseases and Blindness, "A classification and outline of cerebrovascular diseases", Neurology, 8, pp.395~434 (1958)
- Adams HP Jr, "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment", Stroke, 24, pp.35~41 (1993)
- Yasui Y, "Autonomic responses and efferent pathways from the insular cortex in the rat", J Comp Neurol, 303, pp.355~374 (1991)
- Oppenheimer SM, "Cardiovascular effects of human insular cortex stimulation", Neurology, 42, pp.1727~1732 (1992)